Mitsutake Yano

机构：The University of Texas MD Anderson Cancer Center, Oita University · ORCID：0000-0002-4436-838X

发表论文 84 篇 · 总被引 743 次 · h-index 15

代表论文

• PPP2R1A mutations portend improved survival after cancer immunotherapy (2025 · Nature · 被引 30)
• Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma (2023 · Journal of Ovarian Research · 被引 25)
• Usage of nivolumab and ipilimumab for recurrent or advanced malignant vaginal melanoma: a two-case series (2024 · Medical Molecular Morphology · 被引 4)
• Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma (2024 · Human Pathology · 被引 3)
• Genetic Profiling of Sebaceous Carcinoma Arising from an Ovarian Mature Teratoma: A Case Report (2024 · International Journal of Molecular Sciences · 被引 3)
• 777P Targeting cadherin-6 in epithelial ovarian cancer: Clinical significance of its expression and efficacy of raludotatug deruxtecan (R-DXd) in patient-derived cell models (2023 · Annals of Oncology · 被引 3)